• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,649.84 382.50
( 0.52%)
Global Indices
Nasdaq
51,095.09 41.63
(0.08%)
Dow Jones
7,620.62 19.56
(0.26%)
Hang Seng
66,649.95 -284.38
(-0.42%)
Nikkei 225
10,376.42 37.47
(0.36%)
Forex
USD-INR
94.75 -1.18
(-1.23%)
EUR-INR
110.47 -1.07
(-0.96%)
GBP-INR
127.45 -1.26
(-0.98%)
JPY-INR
0.59 -0.01
(-1.17%)

EQUITY - MARKET SCREENER

Natco Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524816
INE987B01026
477.507017
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NATCOPHARM
13.04
16714.53
EPS(TTM)
Face Value()
Div & Yield %
71.55
2
0.54
 

digispice technologies ltd
Board of Indiabulls approves alteration of main object clause of MoA
Dec 19,2025
The board of Indiabulls at its meeting held on 19 December 2025 has approved alteration of main object clause of Memorandum of Association of the Company, subject to necessary approvals, by replacing the existing sub-clauses 1 to 6 with new sub-clauses 1 to 4 of Clause III(A) of the Memorandum of Association of the Company, inter-alia, so as to reflect and make the main objects of the Company consistent with the Core Investment Company, in compliance with applicable regulations of Reserve Bank of India.